Penumbra, Inc. (PEN): A Bull Case Theory [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
Penumbra, Inc.'s share was trading at $357.00 as of January 29th. PEN's trailing and forward P/E were 85.69 and 69.93 respectively according to Yahoo Finance. Penumbra (PEN) is a leading medical device company specializing in thrombectomy, where it effectively operates as the market leader with a near-monopoly position. Its proprietary catheter systems and software allow clinicians to distinguish between clot and blood during removal, making the procedure highly precise and life-saving. This dominance has long supported a premium valuation, as the market consistently prices PEN as a best-in-class operator with durable competitive advantages. Despite the company's fundamental strength, the stock has followed an unusually predictable trading pattern, repeatedly rallying into the low $300s before selling off into the low $200s over the past five years. The most recent pullback, however, is not tied to any deterioration in PEN's operations. Instead, it reflects a broader sector rotati
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra (NYSE:PEN) was downgraded by analysts at UBS Group AG from a "strong-buy" rating to a "hold" rating.MarketBeat
- Halper Sadeh LLC Encourages PEN, FOLD, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PEN, DBRG, FFIC, and FOLDGlobeNewswire
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)GlobeNewswire
- Penumbra (NYSE:PEN) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.MarketBeat
PEN
Earnings
- 11/5/25 - Beat
PEN
Sec Filings
- 2/5/26 - Form SCHEDULE
- 2/4/26 - Form 425
- 1/20/26 - Form 425
- PEN's page on the SEC website